PEDro scores of the reviewed studies
| Reviewed studies | Total scores | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hewett et al31* | 3 | – | X | X | X | |||||||
| Soderman et al18* | 4 | – | X | X | X | X | ||||||
| Heidt et al19 | 5 | – | X | X | X | X | X | |||||
| Myklebust et al20* | 5 | – | X | X | X | X | X | |||||
| Mandelbaum et al21* | 3 | – | X | X | X | |||||||
| Olsen et al22 | 7 | – | X | X | X | X | X | X | X | |||
| Petersen et al30* | 2 | – | X | X | ||||||||
| Pfeiffer et al23* | 2 | – | X | X | ||||||||
| Steffen et al24 | 7 | – | X | X | X | X | X | X | X | |||
| Gilchrist et al25 | 4 | – | X | X | X | X | ||||||
| Pasanen et al26 | 8 | – | X | X | X | X | X | X | X | X | ||
| Kiani et al27* | 4 | – | X | X | X | X | ||||||
| LaBella et al28 | 6 | – | X | X | X | X | X | X | ||||
| Walden et al29 | 7 | – | X | X | X | X | X | X | X |
X: ‘yes’ score. Blank: ‘no’ score. PEDro scale is optimised for the evaluation of randomised control trials; thus, the PEDro assessment score for the non-randomised control should be interpreted with caution. Studies with * are not randomised trial or low-quality randomised trial. 1 Eligibility criteria specified, 2 random allocation of participants, 3 allocation concealed, 4 similar groups at baseline, 5 blinding of participants, 6 blinding of intervention providers, 7 blinding of outcome assessors, 8 outcomes obtained from 85% of participants, 9 use of intent-to-treat analysis if protocol violated, 10 between-group statistical comparison and 11 point measures and measures of variability.